Vaccines A-Z

Precision Vaccinations

 / June 20th, 2024

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Jun 18 • 10:36 am CDT
Recce Pharmaceuticals Ltd. today announced that its primary anti-infective candidate, RECCE® 327 (R327), was added to the World Health Organization's (WHO) report on Antibacterial Agents in Clinical Development and Preclinical Development. The updated WHO report covers... READ →
Jun 18 • 6:51 am CDT
Clover Biopharmaceuticals, Ltd. today announced positive preliminary immunogenicity and safety data in the older adult cohort from its Phase 1 clinical trial evaluating SCB-1019, the company's bivalent RSV prefusion-stabilized F (PreF)-Trimer subunit vaccine candidate, which is based... READ →
Jun 17 • 5:05 pm CDT
Bavarian Nordic A/S today announced the completion of the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for... READ →
Jun 17 • 10:05 am CDT
Today's dynamic digital vaccine news typically involves fact-checking by trusted third parties, but it rarely includes a manufacturer openly responding to a potentially biased article. Recently, the news industry has been challenged in its ability to... READ →
Jun 15 • 3:42 pm CDT
Novavax, Inc. today announced that it has submitted an amendment to its Emergency Use Authorization to the U.S. Food and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine ( NVX-CoV2705 ) for individuals aged 12... READ →

For more articles, try our search.